Christine Cournoyer bought stock once, on Nov 10, 2020
Director at Spok Holdings, Inc., and 1 other company
SEC CIK 0001180466 · Filings on SEC.gov ↗
Christine Cournoyer's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Companies
Every filing
3 filings since Nov 2020, newest first
About Christine Cournoyer
Christine M. Cournoyer is a corporate director and digital health executive who serves on the board of Spok Holdings, Inc., where she became a director in March 2020 and was elected Chair of the Board in July 2022.( At Spok, she also chairs the Nominating and Governance Committee and serves on the Audit Committee, bringing more than 30 years of management experience in software and healthcare IT, including CEO and CIO leadership roles.( In addition to her work with Spok, Cournoyer has served as an independent director of CareDx, Inc., a precision medicine company focused on transplant patients, since 2019 and acts as a strategic advisor to digital health companies.(
Earlier in her career, Cournoyer was CEO and Chairperson of N-of-One, Inc. from 2012 to 2019, where she led its evolution from a patient concierge business into a leading molecular decision support company prior to its acquisition by QIAGEN N.V., for whom she then served as a strategic advisor.( Her prior roles include Vice President of Clinical Analytics at UnitedHealth Group/Optum, President and COO of Picis, and senior leadership positions such as Managing Director, Database Division at Harte Hanks and VP of Global Business Transformation and CIO of the IBM Software Group.( She has also held board positions with BJ’s Wholesale Club, Stride Rite, GTECH, and Emerson Hospital, and has significant public and private board committee experience.( Cournoyer holds a B.S. in Business Administration from the University of Massachusetts, an M.A. in Economics from Northeastern University, and is a graduate of the MIT Executive Education Program.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.